161 related articles for article (PubMed ID: 22288069)
1. Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach.
Fan NJ; Gao CF; Wang CS; Lv JJ; Zhao G; Sheng XH; Wang XL; Li DH; Liu QY; Yin J
Can J Gastroenterol; 2012 Jan; 26(1):41-7. PubMed ID: 22288069
[TBL] [Abstract][Full Text] [Related]
2. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
[TBL] [Abstract][Full Text] [Related]
3. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
Bai Y; Wang J; Gao Z; Dai E
Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
[TBL] [Abstract][Full Text] [Related]
4. Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.
Rho JH; Qin S; Wang JY; Roehrl MH
J Proteome Res; 2008 Jul; 7(7):2959-72. PubMed ID: 18549262
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of serum from pregnant women carrying a fetus with conotruncal heart defect using isobaric tags for relative and absolute quantitation (iTRAQ) labeling.
Zhang Y; Kang Y; Zhou Q; Zhou J; Wang H; Jin H; Liu X; Ma D; Li X
PLoS One; 2014; 9(11):e111645. PubMed ID: 25393621
[TBL] [Abstract][Full Text] [Related]
7. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
8. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed proteins of normal and cancerous human colorectal tissues by liquid chromatograph-mass spectrometer based on iTRAQ approach.
Lv J; Fan N; Wang Y; Wang X; Gao C
Cancer Invest; 2015; 33(9):420-8. PubMed ID: 26180943
[TBL] [Abstract][Full Text] [Related]
10. Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry.
Chen JS; Chen KT; Fan CW; Han CL; Chen YJ; Yu JS; Chang YS; Chien CW; Wu CP; Hung RP; Chan EC
FEBS J; 2010 Jul; 277(14):3028-38. PubMed ID: 20546304
[TBL] [Abstract][Full Text] [Related]
11. In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma.
Gay F; Estornes Y; Saurin JC; Joly-Pharaboz MO; Friederich E; Scoazec JY; Abello J
Hum Pathol; 2008 Oct; 39(10):1420-30. PubMed ID: 18656242
[TBL] [Abstract][Full Text] [Related]
12. Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
Uzozie AC; Selevsek N; Wahlander A; Nanni P; Grossmann J; Weber A; Buffoli F; Marra G
Mol Cell Proteomics; 2017 Mar; 16(3):407-427. PubMed ID: 28062797
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.
Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Dattagupta S; Thakar A; Chauhan SS; Siu KW
J Proteome Res; 2009 Jan; 8(1):300-9. PubMed ID: 19072117
[TBL] [Abstract][Full Text] [Related]
14. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
15. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.
O'Dwyer D; Ralton LD; O'Shea A; Murray GI
PLoS One; 2011; 6(11):e27718. PubMed ID: 22125622
[TBL] [Abstract][Full Text] [Related]
16. Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer.
Tsai MH; Wu CC; Peng PH; Liang Y; Hsiao YC; Chien KY; Chen JT; Lin SJ; Tang RP; Hsieh LL; Yu JS
J Mol Med (Berl); 2012 Feb; 90(2):187-200. PubMed ID: 21997591
[TBL] [Abstract][Full Text] [Related]
17. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
[TBL] [Abstract][Full Text] [Related]
18. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation.
Romero R; Kusanovic JP; Gotsch F; Erez O; Vaisbuch E; Mazaki-Tovi S; Moser A; Tam S; Leszyk J; Master SR; Juhasz P; Pacora P; Ogge G; Gomez R; Yoon BH; Yeo L; Hassan SS; Rogers WT
J Matern Fetal Neonatal Med; 2010 Apr; 23(4):261-80. PubMed ID: 19670042
[TBL] [Abstract][Full Text] [Related]
19. [Differential expression of secretagogin and glucose-related protein 78 in colorectal carcinoma: a proteome study].
Xing XM; Wang YH; Huang Q; Lü BJ; Lai MD
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):107-12. PubMed ID: 17493385
[TBL] [Abstract][Full Text] [Related]
20. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
